Home
Sign in
Listen in app
What does the XARENO study mean for our patients with atrial fibrillation and kidney disease?
CardioCast
Likes
Reposts
In albums
In playlists
Related
XARENO 2 - Year Data - Expert Podcast With Manesh Patel And Peter Rossing
CardioCast
298
10:37
1y
The beginning of the end for NOACs? The extra mile
CardioCast
238
19:31
1y
Extended anticoagulation in patients with VTE: The importance of patient preference
CardioCast
209
19:18
2y
What does the XARENO study mean for our patients with atrial fibrillation and kidney disease?
CardioCast
192
15:10
2y
Anticoagulation in cardiology: Protecting what matters for your patients with VTE
CardioCast
142
19:40
2y
EHRA 2022 - Expert Podcast With John Camm And Keith Fox
CardioCast
243
22:30
2y
Preserving limbs and avoiding repeat revascularization in patients with PAD
CardioCast
128
22:57
2y
Treatment of cancer-associated thrombosis: What is the evidence for rivaroxaban?
CardioCast
164
18:53
2y
Showing all tracks 🏁
Home
Home
Feed
Feed
Search
Search
Library
Library
Download
Download